Transaction · 0001225208-26-001844

Tsourapas Panagiotis

Tsourapas Panagiotis, COO, EUR, APAC, AE, SKIN, reported a transaction classified as exercise at COLGATE PALMOLIVE CO involving 35000.000000 shares for an estimated $2674350.00. Reported holdings after the transaction were 45415.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

exerciseSEC transaction code MCOO, EUR, APAC, AE, SKIN
CLCOLGATE PALMOLIVE CO
Filing timeFeb 13
Trade dateFeb 11, 2026
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$96.67
Pre-filing
1mo ago -15.2%1w ago -2.4%1d ago -2.8%
Returns since
7d -1.6%30d -8.1%90d -8.1%180d -4.5%1y -5.2%

CL price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
CL since 2026-02-13Filed 204 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
exercise
Code M
Identifier
0001225208-26-001844
Common Stock
Transaction date
Feb 11, 2026
Filed Feb 13, 2026, 09:25 PM · 2d delay
Shares
35.0k sh
$7.64k per share
Estimated value
$267M
Computed from shares × price
Holdings after
45.4k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Direct Ownership Large Holdings Increase
+10score
Filing-only score

+10

Compact filing score computed from stored Form 4 facts. Version v1.

Positive filing signal

This filing has a modest positive filing-only score. Treat it as a useful flag for review, not as a buy signal.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

COO, Eur., APac, Afr Eur, Skin

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    Exercise of stock options awarded under the issuer's incentive compensation plan.

  2. F2

    Sale of shares with a portion of the proceeds delivered to the issuer for payment of the exercise price of options under the issuer's incentive compensation plan and the related tax withholding.

  3. F3

    Weighted average price, as these shares were sold in multiple transactions at prices ranging from $94.50 to $94.78 inclusive. The reporting person undertakes to provide to the issuer, any security hol…

  4. F4

    Weighted average price, as these shares were sold in multiple transactions at prices ranging from $97.74 to $97.89 inclusive. The reporting person undertakes to provide to the issuer, any security hol…

  5. F5

    Option became exercisable in one-third increments beginning on the first anniversary of the September 10, 2020 grant date.

Original filing · 0001225208-26-001844
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

CL